Insider · CIK 0001884056

Tan Kevin

Reports to the SEC for 2 companies · CHARLESTOWN, MA

sec.gov

Transactions

Companies

Filings

CIK

0001884056

Forms 4 and 5

Insider transactions

35 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-02-18	SLDBSolid Biosciences Inc.S Sale	CFO & Treasurer	SSale	−5,404 sh	$5.82	−$31.5K	99,422
2026-02-13	SLDBSolid Biosciences Inc.M Exercise/Conversion	CFO & Treasurer	MExercise/Conversion	+10.6K sh	—	—	104,826
2026-02-13	SLDBSolid Biosciences Inc. · Restricted Stock UnitsM Exercise/Conversion	CFO & Treasurer	MExercise/Conversion	−10.6K sh	—	—	21,250
2026-02-04	SLDBSolid Biosciences Inc.S Sale	CFO & Treasurer	SSale	−14.8K sh	$6.44	−$95.2K	94,201
2026-02-02	SLDBSolid Biosciences Inc.S Sale	CFO & Treasurer	SSale	−26.8K sh	$6.44	−$173K	108,984
2026-01-31	SLDBSolid Biosciences Inc.M Exercise/Conversion	CFO & Treasurer	MExercise/Conversion	+33.1K sh	—	—	135,821
2026-01-31	SLDBSolid Biosciences Inc. · Restricted Stock UnitsM Exercise/Conversion	CFO & Treasurer	MExercise/Conversion	−33.1K sh	—	—	99,225
2026-01-29	SLDBSolid Biosciences Inc. · Restricted Stock UnitsA Award	CFO & Treasurer	AAward	+56.6K sh	—	—	56,647
2026-01-29	SLDBSolid Biosciences Inc.M Exercise/Conversion	CFO & Treasurer	MExercise/Conversion	+56.6K sh	—	—	102,746
2026-01-29	SLDBSolid Biosciences Inc. · Performance Stock UnitsM Exercise/Conversion	CFO & Treasurer	MExercise/Conversion	−56.6K sh	—	—	0
2026-01-29	SLDBSolid Biosciences Inc. · Employee Stock Option (Right to Buy)A Award	CFO & Treasurer	AAward	+187K sh	—	—	187,000
2026-01-29	SLDBSolid Biosciences Inc. · Restricted Stock UnitsA Award	CFO & Treasurer	AAward	+93.5K sh	—	—	93,500
2026-01-13	SLDBSolid Biosciences Inc.S Sale	CFO & Treasurer	SSale	−5,704 sh	$5.27	−$30.1K	46,100
2026-01-09	SLDBSolid Biosciences Inc.M Exercise/Conversion	CFO & Treasurer	MExercise/Conversion	+11.3K sh	—	—	51,804
2026-01-09	SLDBSolid Biosciences Inc. · Restricted Stock UnitsM Exercise/Conversion	CFO & Treasurer	MExercise/Conversion	−11.3K sh	—	—	11,250
2025-08-14	SLDBSolid Biosciences Inc. · Employee Stock Option (Right to Buy)A Award	CFO & Treasurer	AAward	+125K sh	—	—	125,000
2025-08-14	SLDBSolid Biosciences Inc. · Restricted Stock UnitsA Award	CFO & Treasurer	AAward	+62.5K sh	—	—	62,500
2025-02-14	SLDBSolid Biosciences Inc.S Sale	CFO & Treasurer	SSale	−3,164 sh	$3.96	−$12.5K	32,250
2025-02-13	SLDBSolid Biosciences Inc.M Exercise/Conversion	CFO & Treasurer	MExercise/Conversion	+10.6K sh	—	—	35,414
2025-02-13	SLDBSolid Biosciences Inc. · Restricted Stock UnitsM Exercise/Conversion	CFO & Treasurer	MExercise/Conversion	−10.6K sh	—	—	31,875
2025-01-31	SLDBSolid Biosciences Inc. · Restricted Stock UnitsA Award	CFO & Treasurer	AAward	+132K sh	—	—	132,300
2025-01-10	SLDBSolid Biosciences Inc.S Sale	CFO & Treasurer	SSale	−4,073 sh	$3.89	−$15.8K	24,789
2025-01-09	SLDBSolid Biosciences Inc.M Exercise/Conversion	CFO & Treasurer	MExercise/Conversion	+11.3K sh	—	—	28,862
2025-01-09	SLDBSolid Biosciences Inc. · Restricted Stock UnitsM Exercise/Conversion	CFO & Treasurer	MExercise/Conversion	−11.3K sh	—	—	22,500
2024-02-13	SLDBSolid Biosciences Inc. · Employee Stock Option (Right to Buy)A Award	CFO & Treasurer	AAward	+85K sh	—	—	85,000
2024-02-13	SLDBSolid Biosciences Inc. · Restricted Stock UnitsA Award	CFO & Treasurer	AAward	+42.5K sh	—	—	42,500
2024-01-09	SLDBSolid Biosciences Inc.M Exercise/Conversion	CFO & Treasurer	MExercise/Conversion	+11.3K sh	—	—	13,243
2024-01-09	SLDBSolid Biosciences Inc.S Sale	CFO & Treasurer	SSale	−3,935 sh	$8.20	−$32.3K	9,308
2024-01-09	SLDBSolid Biosciences Inc. · Restricted Stock UnitsM Exercise/Conversion	CFO & Treasurer	MExercise/Conversion	−11.3K sh	—	—	33,750
2023-01-09	SLDBSolid Biosciences Inc. · Employee Stock Option (Right to Buy)A Award	CFO & Treasurer	AAward	+90K sh	—	—	90,000
2023-01-09	SLDBSolid Biosciences Inc. · Restricted Stock UnitsA Award	CFO & Treasurer	AAward	+45K sh	—	—	45,000
2022-01-03	RNACCartesian Therapeutics, Inc.A Award	Chief Financial Officer	AAward	+72K sh	—	—	77,000
2022-01-03	RNACCartesian Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+340K sh	—	—	340,000
2021-12-02	RNACCartesian Therapeutics, Inc.P Purchase	Chief Financial Officer	PPurchase	+5,000 sh	$3.03	+$15.1K	5,000
2021-09-20	RNACCartesian Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+750K sh	—	—	750,000

Recent filings

Accepted (ET)
Apr 214
Tan Kevin0001193125-26-166732
SEC(opens sec.gov)
Feb 184
Tan Kevin0001193125-26-057855
SEC(opens sec.gov)
Feb 64
Tan Kevin0001193125-26-041514
SEC(opens sec.gov)
Feb 24
Tan Kevin0001193125-26-034089
SEC(opens sec.gov)
Jan 134
Tan Kevin0001193125-26-011873
SEC(opens sec.gov)
Aug 184
Tan Kevin0000950170-25-109735
SEC(opens sec.gov)
Feb 184
Tan Kevin0000950170-25-022202
SEC(opens sec.gov)

Companies

Address

C/O SOLID BIOSCIENCES INC. 500 RUTHERFORD AVENUE, THIRD FLOOR

CHARLESTOWN, MA, 02129